RENCA-IL-2 (Murine Renal Cell Carcinoma transfected with murine IL-2 gene) cells were rejected by immunocompetent (but not T-cell deficient) Balb/c mice, which developed ‘immunity’ to subsequent parental RENCA tumour cell challenge. This evidence concerns the gene IL2 and neoplasm.